New findings may take the art of repurposing one level up. By combining PD-1 checkpoint inhibitors, which are the current stars of cancer immunotherapy, with Cox inhibitors, which have a more checkered history as successful painkillers that were later found to raise the risk of heart attacks, scientists were able to enable mice to overcome a third disease – chronic viral infection.